Sarepta Therapeutics, Inc. 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 4, 2014
Insider Transaction Report
Form 4
Aphale Jayant
SVP Technical Operations
Transactions
- Award
Incentive Stock Option (right to buy)
2014-02-28+1,459→ 1,459 totalExercise: $29.03Exp: 2024-02-28→ Common Stock (1,459 underlying) - Award
Non-Qualified Stock Option (right to buy)
2014-02-28+33,541→ 33,541 totalExercise: $29.03Exp: 2024-02-28→ Common Stock (33,541 underlying)
Footnotes (1)
- [F1]This option is exercisable at the rate of 25% of the shares on the first anniversary of the date of grant and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on the fourth anniversary of the date of grant.